Chronic Lymphocytic Leukemia Market: Expected To Observer Major Growth By 2026
Verfasser: ShashiiPawar on Tuesday, 20 December 2016Chronic lymphocytic leukemia (CLL) is a blood and bone marrow disease that usually gets adverse slowly. It is one of the most common types of leukemia in adults. Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes.It may affect red blood cells, white blood cells, and platelets. Chronic lymphocytic leukemia is the second most common cancer in adult males. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age or middle age. It is rarely seen in people under age 40, and is extremely rare in children. In CLL, majority of the blood stem cells become abnormal lymphocytes healthy white blood cells. The abnormal lymphocytes may also be called leukemia cells. These abnormal lymphocytes are not able to fight infection very well. Also, as the number of lymphocytes increases in the blood and bone marrow, there is less room for healthy white blood cells, red blood cells, and platelets. This may cause infection, anemia, and easy bleeding which may result in death. In 2016, American Cancer Society has estimated that in the United States about18,960 new cases of chronic lymphocytic leukemia (CLL)and approximately 4,660 deaths by CLL are observed up till now.
Chronic Lymphocytic Leukemia Market: Drivers and Restraints